About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Journal of Psychopharmacology
›
top-articles
Journal of Psychopharmacology
3.6
(top 10%)
impact factor
3.8K
(top 5%)
papers
130.0K
(top 5%)
citations
143
(top 5%)
h
-index
3.7
(top 10%)
impact factor
4.3K
all documents
138.5K
doc citations
223
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Journal of Psychopharmacology
2016
1,221
2
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Journal of Psychopharmacology
2016
973
3
5-HT and mechanisms of defence
Journal of Psychopharmacology
1991
868
4
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Journal of Psychopharmacology
2015
768
5
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Journal of Psychopharmacology
2016
755
6
Human hallucinogen research: guidelines for safety
Journal of Psychopharmacology
2008
742
7
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Journal of Psychopharmacology
2010
653
8
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Journal of Psychopharmacology
2011
641
9
Conditioning factors in drug abuse: can they explain compulsion?
Journal of Psychopharmacology
1998
630
10
Pilot study of the 5-HT
2A
R agonist psilocybin in the treatment of tobacco addiction
Journal of Psychopharmacology
2014
613
11
Glutamate and dopamine in schizophrenia: An update for the 21
st
century
Journal of Psychopharmacology
2015
596
12
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Journal of Psychopharmacology
2008
589
13
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
Journal of Psychopharmacology
2005
537
14
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Journal of Psychopharmacology
2015
528
15
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Journal of Psychopharmacology
2014
511
16
Review: Inequalities in healthcare provision for people with severe mental illness
Journal of Psychopharmacology
2010
493
17
The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
Journal of Psychopharmacology
2011
492
18
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Journal of Psychopharmacology
2010
484
19
Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology
Journal of Psychopharmacology
2009
451
20
Asenapine: a novel psychopharmacologic agent with a unique human receptor signature
Journal of Psychopharmacology
2009
451
21
Review: Mortality trends in the general population: the importance of cardiorespiratory fitness
Journal of Psychopharmacology
2010
451
22
Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies
Journal of Psychopharmacology
1999
446
23
Serotonin and brain function: a tale of two receptors
Journal of Psychopharmacology
2017
440
24
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Journal of Psychopharmacology
2008
437
25
Amphetamine, past and present – a pharmacological and clinical perspective
Journal of Psychopharmacology
2013
431
26
Catecholamine regulation of the prefrontal cortex
Journal of Psychopharmacology
1997
423
27
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Journal of Psychopharmacology
2012
420
28
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Journal of Psychopharmacology
2011
406
29
The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications
Journal of Psychopharmacology
1992
403
30
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Journal of Psychopharmacology
2013
373
31
Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology
Journal of Psychopharmacology
2003
369
32
Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines
Journal of Psychopharmacology
2000
367
33
Psychedelics and the essential importance of context
Journal of Psychopharmacology
2018
357
34
Cannabis as a risk factor for psychosis: systematic review
Journal of Psychopharmacology
2005
356
35
Impulsivity: a discussion of clinical and experimental findings
Journal of Psychopharmacology
1999
347
36
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Journal of Psychopharmacology
2011
346
37
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Journal of Psychopharmacology
2011
332
38
NK
1
(TACR
1
) receptor gene ‘knockout’ mouse phenotype predicts genetic association with ADHD
Journal of Psychopharmacology
2010
329
39
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Journal of Psychopharmacology
2015
318
40
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
Journal of Psychopharmacology
2015
317
41
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
Journal of Psychopharmacology
2007
316
42
The other face of depression, reduced positive affect: the role of catecholamines in causation and cure
Journal of Psychopharmacology
2007
311
43
Prolactin and dopamine: What is the connection? A Review Article
Journal of Psychopharmacology
2008
310
44
Treatment of depression: time to consider folic acid and vitamin B12
Journal of Psychopharmacology
2005
309
45
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Journal of Psychopharmacology
2013
306
46
Suicide and schizophrenia
Journal of Psychopharmacology
2001
303
47
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Journal of Psychopharmacology
2016
303
48
A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use
Journal of Psychopharmacology
1998
300
49
Effects of ipsapirone and cannabidiol on human experimental anxiety
Journal of Psychopharmacology
1993
298
50
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users
Journal of Psychopharmacology
2009
294
site/software ©
exaly
; All materials licenced under
CC by-SA
.